Dr. Emad M. Mikhail, MD

Dr. Mikhail practices at Odyssey ASC Endoscopy Center in Irvine, California.

Dr. Mikhail's NPI, 1376582957, was assigned on June 6, 2006. Dr. Mikhail graduated from Keck School of Medicine of USC in 1994. Dr. Mikhail holds California license A54819.

Dr. Mikhail's primary practice is Odyssey ASC Endoscopy Center, at 22 Odyssey, Suite 175, Irvine, CA 92618. The practice phone is (949) 654-8963.

Dr. Mikhail's primary practice is Odyssey ASC Endoscopy Center in Irvine, California. Dr. Mikhail is also affiliated with Hoag Hospital Newport Beach. Dmand AI also links Dr. Mikhail to 1 more physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mikhail practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mikhail's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mikhail is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mikhail is licensed in California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, atrial fibrillation and flutter, chronic anemia, chronic diabetes, chronic hypertension and coronary artery disease among the conditions Dr. Mikhail treats.

CMS data shows 410 Medicare services from Dr. Mikhail across 5 procedure codes in 2024, for 170 Medicare patients. Medicare paid $36,762 for them. Every service was in an office.

CMS counts 170 Medicare patients who saw Dr. Mikhail in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mikhail's median patient age at 58, with 38% women.

In 2024, Dr. Mikhail wrote 4,554 Medicare Part D claims for 383 patients. 89% of them were for generic drugs. CMS names the drug for 4,081 of them, across 72 drugs with 11 or more claims each, at $424,177 in total drug cost. In 2023, CMS named 4,154 claims across 80 drugs.

Dr. Mikhail accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mikhail as offering telehealth.

Dmand AI links 3 papers to Dr. Mikhail, published from 2015 to 2019. 2019 was the busiest year, with 2. Dr. Mikhail has published most often in J Minim Invasive Gynecol. Dr. Mikhail's most frequent co-authors are Anthony Nosa Imudia, MD, Emad Mounir Mikhail, MD and Marisa F. Baker, MD.

CMS Open Payments shows 13 general payments to Dr. Mikhail from 6 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 53% of the total. Covidien LP paid the most, $525.

Dmand AI lists 1 award for Dr. Mikhail, most recently CMS Stage 1 EHR in 2013.

Dr. Mikhail graduated from Keck School of Medicine of USC in 1994.

Dr. Mikhail is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.